An injectable in situ hydrogel platform for sustained drug release against Glioblastoma
{{output}}
Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. Despite aggressive surgical and medical treatments, the prognosis for patients with GBM remains grim and tumor recurrence is inevitable. Long-acting localized chemotherapy can n... ...